SirVir obtained positive results in pre-clinical experiment against COVID-19
SirVir, a subsidiary of Aposense, and the Israeli Institute for Biological Research (IIBR) announce positive results in their pre-clinical collaborative study in the eradication of the Corona virus COVID-19